Galatea Kallergi - Search Results

Year	Number of Results
2003	1
2007	2
2008	3
2009	5
2010	1
2011	2
2013	2
2014	3
2015	2
2016	1
2017	5
2018	4
2019	2
2020	2
2021	5
2022	6
2023	1

1

Circulating tumor cells as prognostic biomarkers in breast cancer: current status and future prospects.

Chantzara E, Xenidis N, Kallergi G, Georgoulias V, Kotsakis A. Chantzara E, et al. Among authors: kallergi g. Expert Rev Mol Diagn. 2021 Oct;21(10):1037-1048. doi: 10.1080/14737159.2021.1962710. Epub 2021 Aug 9. Expert Rev Mol Diagn. 2021. PMID: 34328384 Review.

2

Epithelial-to-mesenchymal transition of tumor cells: cancer progression and metastasis.

Vardas V, Politaki E, Pantazaka E, Georgoulias V, Kallergi G. Vardas V, et al. Among authors: kallergi g. Int J Dev Biol. 2022;66(1-2-3):277-283. doi: 10.1387/ijdb.210180gk. Int J Dev Biol. 2022. PMID: 34881791

3

PARP-1 Expression and BRCA1 Mutations in Breast Cancer Patients' CTCs.

Sklias T, Vardas V, Pantazaka E, Christopoulou A, Georgoulias V, Kotsakis A, Vasilopoulos Y, Kallergi G. Sklias T, et al. Among authors: kallergi g. Cancers (Basel). 2022 Mar 29;14(7):1731. doi: 10.3390/cancers14071731. Cancers (Basel). 2022. PMID: 35406503 Free PMC article.

4

Clinical Relevance of Mesenchymal- and Stem-Associated Phenotypes in Circulating Tumor Cells Isolated from Lung Cancer Patients.

Pantazaka E, Vardas V, Roumeliotou A, Kakavogiannis S, Kallergi G. Pantazaka E, et al. Among authors: kallergi g. Cancers (Basel). 2021 Apr 29;13(9):2158. doi: 10.3390/cancers13092158. Cancers (Basel). 2021. PMID: 33947159 Free PMC article. Review.

5

Membrane androgen receptor activation in prostate and breast tumor cells: molecular signaling and clinical impact.

Papadopoulou N, Papakonstanti EA, Kallergi G, Alevizopoulos K, Stournaras C. Papadopoulou N, et al. Among authors: kallergi g. IUBMB Life. 2009 Jan;61(1):56-61. doi: 10.1002/iub.150. IUBMB Life. 2009. PMID: 19109827 Free article. Review.

6

Phenotypic Characterization of Circulating Tumor Cells Isolated from Non-Small and Small Cell Lung Cancer Patients.

Roumeliotou A, Pantazaka E, Xagara A, Dimitrakopoulos FI, Koutras A, Christopoulou A, Kourelis T, Aljarba NH, Alkahtani S, Koinis F, Kotsakis A, Kallergi G. Roumeliotou A, et al. Among authors: kallergi g. Cancers (Basel). 2022 Dec 28;15(1):171. doi: 10.3390/cancers15010171. Cancers (Basel). 2022. PMID: 36612166 Free PMC article.

7

PD-L1/pS6 in Circulating Tumor Cells (CTCs) during Osimertinib Treatment in Patients with Non-Small Cell Lung Cancer (NSCLC).

Pantazaka E, Ntzifa A, Roumeliotou A, Lianidou E, Georgoulias V, Kotsakis A, Kallergi G. Pantazaka E, et al. Among authors: kallergi g. Biomedicines. 2022 Aug 5;10(8):1893. doi: 10.3390/biomedicines10081893. Biomedicines. 2022. PMID: 36009440 Free PMC article.

8

Detyrosinated α-Tubulin, Vimentin and PD-L1 in Circulating Tumor Cells (CTCs) Isolated from Non-Small Cell Lung Cancer (NSCLC) Patients.

Katsarou SD, Messaritakis I, Voumvouraki A, Kakavogiannis S, Κotsakis A, Alkahtani S, Stournaras C, Martin SS, Georgoulias V, Kallergi G. Katsarou SD, et al. Among authors: kallergi g. J Pers Med. 2022 Jan 25;12(2):154. doi: 10.3390/jpm12020154. J Pers Med. 2022. PMID: 35207643 Free PMC article.

9

A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer.

Strati A, Zavridou M, Kallergi G, Politaki E, Kuske A, Gorges TM, Riethdorf S, Joosse SA, Koch C, Bohnen AL, Mueller V, Koutsodontis G, Kontopodis E, Poulakaki N, Psyrri A, Mavroudis D, Georgoulias V, Pantel K, Lianidou ES. Strati A, et al. Among authors: kallergi g. Clin Chem. 2021 Oct 1;67(10):1395-1405. doi: 10.1093/clinchem/hvab099. Clin Chem. 2021. PMID: 34322698

10

Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy.

Kallergi G, Kontopodis E, Ntzifa A, Jordana-Ariza N, Karachaliou N, Pantazaka E, Charalambous HA, Psyrri A, Tsaroucha E, Boukovinas I, Koumarianou A, Hatzidaki D, Lianidou E, Georgoulias V, Rosell R, Kotsakis A. Kallergi G, et al. Cancers (Basel). 2022 Mar 19;14(6):1574. doi: 10.3390/cancers14061574. Cancers (Basel). 2022. PMID: 35326725 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results